- Home
- PRLD vs ORGN Comparison
PRLD vs ORGN Comparison
Compare PRLD & ORGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRLD
- ORGN
- Stock Information
- Founded
- PRLD 2016
- ORGN 2008
- Country
- PRLD United States
- ORGN United States
- Employees
- PRLD N/A
- ORGN N/A
- Industry
- PRLD Medicinal Chemicals and Botanical Products
- ORGN Major Chemicals
- Sector
- PRLD Health Care
- ORGN Industrials
- Exchange
- PRLD Nasdaq
- ORGN Nasdaq
- Market Cap
- PRLD 73.7M
- ORGN 83.0M
- IPO Year
- PRLD 2020
- ORGN N/A
- Fundamental
- Price
- PRLD $0.81
- ORGN $0.60
- Analyst Decision
- PRLD Strong Buy
- ORGN Strong Buy
- Analyst Count
- PRLD 2
- ORGN 1
- Target Price
- PRLD $4.50
- ORGN $3.00
- AVG Volume (30 Days)
- PRLD 279.1K
- ORGN 1.1M
- Earning Date
- PRLD 05-06-2025
- ORGN 05-13-2025
- Dividend Yield
- PRLD N/A
- ORGN N/A
- EPS Growth
- PRLD N/A
- ORGN N/A
- EPS
- PRLD N/A
- ORGN N/A
- Revenue
- PRLD $7,000,000.00
- ORGN $31,282,000.00
- Revenue This Year
- PRLD N/A
- ORGN $83.02
- Revenue Next Year
- PRLD N/A
- ORGN $24.18
- P/E Ratio
- PRLD N/A
- ORGN N/A
- Revenue Growth
- PRLD N/A
- ORGN 8.60
- 52 Week Low
- PRLD $0.61
- ORGN $0.42
- 52 Week High
- PRLD $6.80
- ORGN $1.90
- Technical
- Relative Strength Index (RSI)
- PRLD 57.52
- ORGN 40.65
- Support Level
- PRLD $0.71
- ORGN $0.52
- Resistance Level
- PRLD $0.72
- ORGN $0.65
- Average True Range (ATR)
- PRLD 0.08
- ORGN 0.06
- MACD
- PRLD 0.02
- ORGN 0.01
- Stochastic Oscillator
- PRLD 76.92
- ORGN 62.67
About PRLD Prelude Therapeutics Incorporated
Prelude Therapeutics Incorp is a clinical-stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.
About ORGN Origin Materials Inc.
Origin Materials Inc is a carbon-negative materials company. The platform turns the carbon found in biomass into useful materials, while eliminating the need for fossil resources and capturing carbon in the process. Its products include, PET circular caps and closures, Para-xylene, carbon black, Levulinic acid among others by using materials like food and beverage packaging, clothing, textiles, plastics, car parts, carpeting, tires, adhesives, soil amendments, and fuels.